Skip to main content

Peer Review reports

From: A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma

Original Submission
6 Dec 2020 Submitted Original manuscript
20 Jan 2021 Author responded Author comments - Jiujie Cui
Resubmission - Version 2
20 Jan 2021 Submitted Manuscript version 2
7 Mar 2021 Reviewed Reviewer Report
11 Mar 2021 Reviewed Reviewer Report
19 Mar 2021 Reviewed Reviewer Report
19 Mar 2021 Reviewed Reviewer Report
23 Apr 2021 Author responded Author comments - Jiujie Cui
Resubmission - Version 3
23 Apr 2021 Submitted Manuscript version 3
27 Apr 2021 Reviewed Reviewer Report
28 Apr 2021 Reviewed Reviewer Report
1 May 2021 Reviewed Reviewer Report
4 May 2021 Reviewed Reviewer Report
13 May 2021 Author responded Author comments - Jiujie Cui
Resubmission - Version 4
13 May 2021 Submitted Manuscript version 4
Publishing
18 May 2021 Editorially accepted
7 Jun 2021 Article published 10.1186/s12885-021-08375-6

You can find further information about peer review here.

Back to article page